Drug Trial Radar · NCT07190482
Treatment of Tinnitus With Olanzapine
Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Oct 1, 2023
Primary completion
Dec 20, 2024
Study completion Jan 20, 2025
Sponsor
- Lead sponsor
- University of Sao PauloAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This research aims to evaluate the effects of the drug olanzapine on the discomfort caused by tinnitus according to each patient's personality traits. Olanzapine is a drug used as an antipsychotic whose mechanism of action makes it potentially useful for the treatment of tinnitus.
Conditions
- Tinnitus
- Tinnitus, Subjective
Interventions
Olanzapine 5 Mg ORAL TABLETDrug
OLANZAPINE ARM
Placebo DrugDrug
placebo administered for 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the efficacy of olanzapine in reducing tinnitus symptoms in a randomized placebo-controlled crossover trialTime frame: From enrollment to the end of treatment at 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Ethics Committee (CEP)
São Paulo, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.